Ashland Global Holdings Inc. announced Ashok Kalyana will be joining Ashland, to lead the Life Sciences business unit, effective January 31, 2020. Kalyana will report directly to Guillermo Novo, chairman and chief executive officer. Most recently, Kalyana led Tate & Lyle’s Asia Pacific commercial and business development. Prior to that he led specialty materials businesses with Dow Chemical and Rohm and Haas.